![Susan Graf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Graf
Direttore/Membro del Consiglio presso
CG ONCOLOGY, INC.
Patrimonio netto: - $ in data 31/08/2026
Profilo
Susan E.
Graf is currently Director at Kaleo, Inc. since 2021, Independent Director at CG Oncology, Inc. since 2023, and Independent Director at Aardvark Therapeutics, Inc. since 2024.
Former roles include Chief Executive Officer at Akamara Therapeutics, Inc. from 2019 to 2021, Independent Chairman at Finch Therapeutics Group, Inc. from 2022 to 2024, Director at Vitrisa Therapeutics, Inc., Vice President-Corporate Development & Strategy at NPS Pharmaceuticals, Inc. from 2013 to 2015, and Chief Financial & Business Officer at Epizyme, Inc. from 2016 to 2018.
Education includes undergraduate studies at Purdue University and an MBA from The Leonard N Stern School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CG ONCOLOGY, INC. -.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| 14/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Posizioni attive di Susan Graf
| Società | Posizione | Inizio |
|---|---|---|
| CG ONCOLOGY, INC. | Direttore/Membro del Consiglio | 20/11/2023 |
| AARDVARK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/11/2024 |
Kaleo, Inc.
 Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products | Direttore/Membro del Consiglio | 01/12/2021 |
Precedenti posizioni note di Susan Graf
| Società | Posizione | Fine |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Presidente | 01/03/2024 |
Akamara Therapeutics, Inc.
 Akamara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Amministratore Delegato | 01/05/2021 |
| EPIZYME, INC. | Direttore Finanziario/CFO | 30/09/2018 |
| NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2015 |
Vitrisa Therapeutics, Inc.
 Vitrisa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | - |
Formazione di Susan Graf
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
61
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
Kaleo, Inc.
Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Finch Therapeutics Group, Inc.
 Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Vitrisa Therapeutics, Inc.
Vitrisa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Akamara Therapeutics, Inc.
Akamara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
